NONMEM Users Network Archive

Hosted by Cognigen

[NMusers] Two positons open at EMD Serono in Billerica (MA) for Pharmacometric site head and senior scientist

From: Akash Khandelwal <akash.khandelwal_at_merckgroup.com>
Date: Thu, 20 Apr 2017 06:55:09 +0000

With correct requisition ID for site head : 154871

On Behalf of Pascal Girard.



Dear NONMEM Users,



EMD Serono is the North American biopharma brand of Merck KGaA, Darmstadt, =
Germany - a leading science and technology company - focused exclusively on=
 specialty care. For more than 40 years, the brand has integrated cutting-e=
dge science, innovative products and industry-leading patient support and a=
ccess programs. EMD Serono has deep expertise in neurology, fertility, endo=
crinology, oncology as well as a robust pipeline of potential therapies in =
oncology, immunology and immuno-oncology as shown by recently approved avel=
umab (anti-PDL1 drug) in Merkel Cell Carcinoma.



EMD Serono is recruiting for a Site Head of Pharmacometry and a senior scie=
ntist pharmacometrician to be located in Billerica, MA.

To apply for site head, please visit the careers pages on https://career012=
.successfactors.eu/career?company=merckgroup and enter the Requisition ID=
: 154871. To apply for senior scientist pharmacometrician use requisition I=
D: 155222.



Pharmacometric Department of EMD-Serono, part of Global Early Development /=
 Quantitative Pharmacology , contributes to clinical development efficiency=
 by providing core expertise modeling & simulation in the quantification of=
 the relationship between dose, exposure and responses, and factors affecti=
ng its variability. The Site Head of Pharmacometry will build the local tea=
m and lead it to success, in close collaboration with global head of Pharma=
cometry based in Europe and Global of Clinical Pharmacology based in Biller=
ica.



PURPOSE OF THE SITE HEAD ROLE

The site head will report to the global head of pharmacometry. He will have=
 her/his own pharmacometric project and will also have to recruit, train, l=
ead and provide input and guidance to a local team of senior pharmacometric=
ians who develop M&S methodologies and expertise in drug development and ma=
ke them available to facilitate more efficient and informative clinical tri=
als, inform decision making, and globally support Clinical Pharmacology, Cl=
inical Teams and Projects. Main tasks will be:

* Recruit and Lead the newly created team.

* Own projects and design, execute, supervise and report pharmacokinetic/ph=
armacodynamic (PK/PD).

* Utilize modeling and simulation analysis in order to support model inform=
ed drug development discovery.

* Interact with clinical pharmacology, clinician and biostatistics teams.

* Keep up-to-date with scientific development in PK/PD and share expertise =
with colleagues.



QUALIFICATIONS OF THE SITE HEAD:

* A PhD, MD, PharmD or Master and a minimum 10 years' experience in PK/PD M=
odeling, with a minimum of 5 in (Bio)Pharmaceutical Industry are required

* NONMEM and R experience is required.

* Experience with XPose, PsN, MONOLIX, SIMULX, SIMCYP or similar pharmacome=
tric modeling and simulation software is strongly preferred.

* Demonstrated strong potential leadership in pharmacometry and management =
of people is required

* Ability to communicate technical results and details effectively with sci=
entists and clinicians is required.

* Experience working in a dynamic matrix organization is also required.

* Ability to be a team-player and work cross functionally is required.



PURPOSE OF THE SENIOR SCIENTIST ROLE:

* Elaborate, design, execute and report pharmacokinetic/pharmacodynamic (PK=
/PD)

* Utilize modeling and simulation analysis to support model informed drug d=
evelopment discovery.

* Collaborate with pharmacology, clinical and biostatistics teams.

* Keep up-to-date with scientific development in PK/PD and share your own e=
xpertise with pharmacometric colleagues.



QUALIFICATIONS OF THE SENIOR SCIENTIST

* A PhD, MD, PharmD or Masters with a minimum of 4 years' experience in PK/=
PD Modeling, and 2 years' experience in (Bio)Pharmaceutical Industry are re=
quired.

* NONMEM and R/SAS experience is also required

* Experience with XPose, PsN, MONOLIX, SIMULX, SIMCYP, or similar pharmacom=
etric modeling and simulation software is strongly preferred.

* Ability to communicate technical results and details effectively with sci=
entists and clinicians is required.

* Experience working in a dynamic matrix organization is also required

* Ability to be a team player and work cross functionally is also required.



To apply for site head or senior scientist pharmacometrician, please visit =
the careers pages on https://career012.successfactors.eu/career?company=m=
erckgroup and enter the Requisition ID: 154871 or 155222, respectively.



With best regards,



Dr. Pascal Girard, Director, Head of Pharmacometry Biopharma | Global Early=
 Development | QPD | QP



Akash Khandelwal PhD
Associate Director, Pharmacometry
Biopharma | R&D Global Early Development

Merck
Merck KGaA | Frankfurter Str. 250 |postcode: F130/132 | 64293 Darmstadt
Phone: +49 615 172 433 23 | Mobile: +49 151 145 474 05| Fax: +49 6151 72-56=
684
Email: akash.khandelwal_at_merckgroup.com<mailto:akash.khandelwal_at_merckgroup.c=
om> | www.merckgroup.com<http://www.merckgroup.com/>
Mandatory information can be found at: http://www.merckgroup.com/mandatorie=
s










This message and any attachment are confidential and may be privileged or o=
therwise protected from disclosure. If you are not the intended recipient, =
you must not copy this message or attachment or disclose the contents to an=
y other person. If you have received this transmission in error, please not=
ify the sender immediately and delete the message and any attachment from y=
our system. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do n=
ot accept liability for any omissions or errors in this message which may a=
rise as a result of E-Mail-transmission or for damages resulting from any u=
nauthorized changes of the content of this message and any attachment there=
to. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do not guara=
ntee that this message is free of viruses and does not accept liability for=
 any damages caused by any virus transmitted therewith.



Click http://www.merckgroup.com/disclaimer to access the German, French, Sp=
anish and Portuguese versions of this disclaimer.


Received on Thu Apr 20 2017 - 02:55:09 EDT

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to: nmusers-request@iconplc.com. Once subscribed, you may contribute to the discussion by emailing: nmusers@globomaxnm.com.